Expression Of Cyclin D1 Protein Isoforms And Its Prognostic Significance In Cervical Cancer

References

• Shen MR, Hsu YM, Hsu KF, et al. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling. Carcinogenesis. 2006;27(5):962–71. doi:10.1093/carcin/bgi33616400188
   PubMed Web of Science ®Google Scholar
• Pan Y, Zhang Y, Chen L, et al. The critical role of Rab31 in cell proliferation and apoptosis in cancer progression. Mol Neurobiol. 2015.
   Web of Science ®Google Scholar
• Galloway TJ, Ridge JA. Management of squamous cancer metastatic to cervical nodes with an unknown primary site. J Clin Oncol. 2015;33:3328–3337. doi:10.1200/JCO.2015.61.006326351351
   PubMed Web of Science ®Google Scholar
• Biglia N, Bounous VE, Sgro LG, D’Alonzo M, Gallo M. Treatment of climacteric symptoms in survivors of gynaecological cancer. Maturitas. 2015;82:296–298. doi:10.1016/j.maturitas.2015.07.00626341044
   PubMed Web of Science ®Google Scholar
• Yan J, Zhang Y, Ren C, et al. Involvement of nuclear protein C23 in activation of EGFR signaling in cervical cancer. Tumour Biol. 2015.
   Google Scholar
• Nicolaidis S. Biomarkers of cervical cancer multiforme. Metabolism. 2015;64:S22–S27. doi:10.1016/j.metabol.2014.10.03125468141
   PubMed Web of Science ®Google Scholar
• SH S, Liu D, Deng YT, et al. SIX1 coordinates with TGFβ signals to induce epithelial-mesenchymal transition in cervical cancer. Oncol Lett. 2016;12:1271–1278. doi:10.3892/ol.2016.479727446426
   PubMed Web of Science ®Google Scholar
• Zhang -Y-Y, Zhang F, Zhang Y-S, et al. Mechanism of juglone-induced cell cycle arrest and apoptosis in Ishikawa Human endometrial cancer cells. J Agric Food Chem. 2019;67(26 ):7378–7389. doi:10.1021/acs.jafc.9b0275931184118
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang YS, Thakur K, et al. Licochalcone A from licorice root, an inhibitor of human hepatoma cell growth via induction of cell apoptosis and cell cycle arrest. Food Chem Toxicol. 2018;120:407–417. doi:10.1016/j.fct.2018.07.04430055311
   PubMed Web of Science ®Google Scholar
• Shuo Q, Diehl JA. Cyclin D1, cancer progression and opportunities in cancer treatment. J Mol Med (Berl). 2016;94(12 ):1313–1326. doi:10.1007/s00109-016-1475-327695879
   PubMed Web of Science ®Google Scholar
• Jia R, Suhui WU, Guo H, et al. Effects of MIF recombinant plasmid transfection on human cervical cancer cells SiHa and Its influence on CyclinD1 expression. Cancer Res Prev Treat. 2013;28(32 ):834–838.
   Google Scholar
• Bali A, O’Brien PM, Edwards LS, Sutherland RL, Hacker NF, Henshall SM. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer. Clin Cancer Res. 2004;10:5168–5177. doi:10.1158/1078-0432.CCR-03-075115297421
   PubMed Web of Science ®Google Scholar
• Casimiro MC, Di Sante G, Di Rocco A, et al. Cyclin D1 restrains oncogene-induced autophagy by regulating the AMPK-LKB1 signaling axis. Cancer Res. 2017;77(13 ):3391–3405. doi:10.1158/0008-5472.CAN-16-042528522753
   PubMed Web of Science ®Google Scholar
• Yi Y, Li H, Lv Q, et al. miR-202 inhibits the progression of human cervical cancer through inhibition of cyclin D1. Oncotarget. 2016;7(44 ):72067–72075. doi:10.18632/oncotarget.1249927732565
   PubMedGoogle Scholar
• Bates S, Parry D, Bonetta L, Vousden K, Dickson C, Peters G. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene. 1994;9:1633–1640.8183557
   PubMed Web of Science ®Google Scholar
• Wang N, Qian X, Wang S, et al. CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population. Mol Carcinog. 2012;51:196–205. doi:10.1002/mc.2080121594903
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 2004;18:2699–2711. doi:10.1101/gad.125650415545627
   PubMed Web of Science ®Google Scholar
• Deshpande A, Sicinski P, Hinds PW. Cyclins and cdks in development and cancer: a perspective. Oncogene. 2005;24:2909–2915. doi:10.1038/sj.onc.120861815838524
   PubMed Web of Science ®Google Scholar
• Hosokawa Y, Arnold A. Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression. Genes Chromosomes Cancer. 1998;22:66–71.9591636
   PubMed Web of Science ®Google Scholar
• Chen H, Xu X, Wang G, et al. CDK4 protein is degraded by anaphase-promoting complex/cyclosome in mitosis and reaccumulates in early G1 phase to initiate a new cell cycle in HeLa cells. J Biol Chem. 2017;292(24 ):10131–10141. doi:10.1074/jbc.M116.77322628446612
   PubMed Web of Science ®Google Scholar
• Y E S-W, M W W, Chen QR. Expression of USP2 and CyclinD1 in Gastric Carcinoma and Its Clinicopathologic Significance. China Cancer. 2014;20(35 ):830–838.
   Google Scholar
• Howe D, Lynas C. The cyclin D1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the poly-morphism at codon 241. Haematologica. 2001;86:563–569.11418364
   PubMed Web of Science ®Google Scholar
• Reis-Filho JS, Savage K, Lambros MB, et al. Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis. Mod Pathol. 2006;19:999–1009. doi:10.1038/modpathol.380062116648863
   PubMed Web of Science ®Google Scholar
• Hosooka T, Ogawa W. A novel role for the cell cycle regulator complex cyclin D1-CDK4 in gluconeogenesis. J Diabetes Investig. 2016;7(1 ):27–28. doi:10.1111/jdi.12369
   PubMed Web of Science ®Google Scholar
• Bonilla C, Lefèvre JH, Winney B, et al. Cyclin D1 rare variants in UK multiple adenoma and early-onset colorectal cancer patients. J Hum Genet. 2011;56:58–63. doi:10.1038/jhg.2010.14421107342
   PubMed Web of Science ®Google Scholar
• Hayakawa Y, Hirata Y, Nakagawa H, et al. Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer. Proc Natl Acad Sci USA. 2011;108:780–785. doi:10.1073/pnas.101141810821187402
   PubMed Web of Science ®Google Scholar
• Skomedal H, Kristensen GB, Lie AK, Holm R. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. Gynecol Oncol. 1999;73:223–228. doi:10.1006/gyno.1999.534610329038
   PubMed Web of Science ®Google Scholar
• Bae DS, Cho SB, Kim YJ, et al. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol. 2001;81:341–347. doi:10.1006/gyno.2001.619611371120
   PubMed Web of Science ®Google Scholar
• Massague J. G1 cell-cycle control and cancer. Nature. 2004;432:298–306. doi:10.1038/nature0309415549091
   PubMed Web of Science ®Google Scholar
• Lange C, Huttner WB, Calegari F. Cdk4/cyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors. Cell Stem Cell. 2009;5:320–331. doi:10.1016/j.stem.2009.05.02619733543
   PubMed Web of Science ®Google Scholar
• Ramos-Garcia P, Gil-Montoya JA, Scully C, et al. An update on the implications of cyclin D1 in oral carcinogenesis. Oral Dis. 2017;23(7 ):897–912. doi:10.1111/odi.1262027973759
   PubMed Web of Science ®Google Scholar
• Wang N, Wei H, Yin D, et al. Cyclin D1b overexpression inhibits cell proliferation and induces cell apoptosis in cervical cancer cells in vitro and in vivo. Int J Clin Exp Pathol. 2014;7(7 ):4016–4023.25120779
   PubMed Web of Science ®Google Scholar
• Jirawatnotai S, Sittithumcharee G. Paradoxical roles of cyclin D1 in DNA stability. DNA Repair (Amst). 2016;42:56–62. doi:10.1016/j.dnarep.2016.04.01127155130
   PubMed Web of Science ®Google Scholar